1 / 24

A.S.L. 14 Chioggia

A.S.L. 14 Chioggia. 1° Conferenza Regionale sul Diabete Mellito. Dr. Angelo Boscolo Bariga. Verona !2-13 dicembre 2008. L’impatto del prediabete.

Download Presentation

A.S.L. 14 Chioggia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. A.S.L. 14 Chioggia 1° Conferenza Regionale sul Diabete Mellito Dr. Angelo Boscolo Bariga Verona !2-13 dicembre 2008 L’impatto del prediabete

  2. Il diabete è un insieme di disordini caratterizzati da valori glicemicielevati che causano complicazioni renali,oculari e nervose uniche e aumentano il rischio di patologia cardiovascolare.

  3. Prediabete e microangiopatia

  4. Retinopatia 7.6% Prevalenza nell’ IGT 6-12 mesi 12.5% diabete Hamman RF 65th annual meeting of ADA 2005

  5. Retinopatia Soglia glicemica per la retinopatia 108-130 mg/dl A digiuno 155 - 215 mg/dl 2h dopo carico orale Engelgau MM diabetes care 20: 785-791 1997

  6. Microalbuminuria Non diabetici 4% 16% IGT Metcalf PA diabetes 16 1485-1493 1993

  7. Neuropatia Prevalenza della polineuropatia simmetrica in soggetti egiziani Normali 4% 10% IGT 13.6% Diabete neo diagnosticato Herman WH diabetes care 15: 1045-1051, 1998

  8. Neuropatia Prevalenza dell’ IGT in soggetti con neuropatia sensoriale dolorosa idiopatica 30-50% Singleton et al diabetes care 24: 1448-1453, 2001

  9. Prediabete e macroangiopatia

  10. Anche la condizione di IFG è a maggior rischio di shock cardiogeno post-IMA Impaired fasting glucose and cardiogenic shock in patients with acute myocardial infarction Zeller M et al, European Heart Journal 25:308-312,2004 99 pt with acute MI 38% DM, 15%IFG, 47% NFG P=0.011 P=0.003 Fasting BG mmol/l % Cardiogenic shock NFG IFG No Shock Shock

  11. 2-hour PPG, Not FPG, PredictedAll-cause Mortality 2.5 2.0 1.5 1.0 0.5 0.0 Hazard ratio ³11.1 7.8 –11.0 2-hour PPG, 75g OGTT(mmol/L) <7.8 <6.1 6.1– 6.9 ³7.0 Fasting plasma glucose (mmol/L) Adjusted for age, centre, sex www.diabetesclinic.ca Adapted from DECODE Study Group. Lancet 1999;354:617.

  12. Epidemiological Evidence Linking High PPG* with CVD Risk & Mortality DECODE, 19991High PPG is associated with increased risk of death, independent of FPG Pacific and Indian Ocean, 19992 High PPG with normal FPG doubles the risk of mortality Funagata Diabetes Study, 19993IGT, but not IFG, is a risk factor for CVD Whitehall, Paris, Helsinki Study 19984 Men in upper 2.5% of PPG distribution had significantly higher CHD mortality The Rancho-Bernardo Study, 19985 PPG more than doubles the risk of fatal CVD and heart disease in older adults Diabetes Intervention Study, 19966PPG (1-hr post-breakfast), but not FPG, is associated with CHD *2-hour PPG after 75g OGTT, except where indicated www.diabetesclinic.ca 1DECODE Study Group. Lancet 1999;354:617. 2Shaw JE et al. Diabetologia 1999;42:1050. 3Tominaga M et al. Diabetes Care 1999;22:920. 4Balkau B et al. Diabetes Care 1998;21:360. 5Barrett-Connor E et al. Diabetes Care 1998;21:1236. 6Hanefeld M et al. Diabetologia 1996;39:1577.

  13. La ridotta tolleranza ai carboidrati è un fattore di rischio cardiovascolare: The Funagata Diabetes Study NGT IGT Diabete Mortalità per tutte le cause Mortalità cardiovascolare 1,000 1,000 0,980 0,990 * * 0,960 0,980 * * * * 0,940 0,970 * * * * * * * * 0,920 0,960 * 0,900 0,950 * 0,880 0,940 0 1 2 3 4 5 6 7 0 1 2 3 4 5 6 7 anni anni Mod. da Tominaga M, et al. Diabetes Care 1999; 22: 920-924.

  14. 66% of AMI patients have IGT or previously undiagnosed T2DM on 75 g OGTT (35% IGT; 31% DM) Percentage of Population (n = 1181) Prevalence of Hyperglycemia in 181 Cardiac Patients Without Known Diabetes Norhammar A. Lancet. 2002;359:2140-2144.

  15. Anche per la glicemia , come per il colesterolo si può dire: • “Lower is better?”

  16. Rischio relativo cardiovascolare in rapporto allo status di diabete Frank B. Hush et al. Diabetes Care – N. 13 – set. 2002

  17. Rischio relativo cardiovascolare in base al tempo precedente la diagnosi di diabete Frank B. Hush et al. Diabetes Care – N. 13 – set. 2002

  18. Earlier is better ?

  19. Grazie per l’attenzione

More Related